Use of modified cyclosporins for the treatment of HCV disorders

Details for Australian Patent Application No. 2004268382 (hide)

Owner Novartis AG

Inventors Watashi, Koichi; Hijikata, Makoto; Shimotohno, Kunitada

Agent Davies Collison Cave

Pub. Number AU-A-2004268382

PCT Pub. Number WO2005/021028

Priority 0320638.0 03.09.03 GB

Filing date 2 September 2004

Wipo publication date 10 March 2005

International Classifications

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/021028 Priority application(s): WO2005/021028

31 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268383-Proton pump inhibitor formulations, and methods of preparing and using such formulations

2004268381-Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep